Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting - A follow-up study
S. Sallah et al., Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting - A follow-up study, CANCER, 92(6), 2001, pp. 1349-1353
BACKGROUND. Chronic disseminated candidiasis (CDC) is a serious complicatio
n of treatment in patients with acute leukemia. Although some general risk
factors are known to predispose to systemic fungal infections, few studies
have addressed the relevance of certain clinical and laboratory features in
patients with CDC.,
PATIENTS AND METHODS. To define a subset of patients at high risk for CDC,
the authors evaluated the demographics and clinical and laboratory characte
ristics of 423 patients with acute leukemia. Patients who had bone marrow t
ransplant before the diagnosis of CDC were excluded from the analysis. The
diagnosis of CDC was based on blood cultures, liver biopsy, and imaging stu
dies. The authors conducted 2 separate regression analyses on 3 subsets of
patients: patients without documented candidiasis (n = 374), patients with
CDC (n = 23), and patients with candidemia (n = 26).
RESULTS. According to multivariate analysis, younger age (P = 0.009; odds r
atio [OR], 1.96; 95% confidence interval [CI], 1.72-2.99), duration of neut
ropenia of 15 days or longer (P = 0.0003; OR, 11.7; 95% CI, 3.04-45.1), and
use of prophylactic quinolone antibiotics (P = 0.039; OR, 3.85; 95% CI, 1.
11-13.4) emerged as independent factors related to the development of CDC i
n patients with acute leukemia. The presence of severe mucositis, colonizat
ion with Candida, and administration of high-dose ara-C were statistically
significant parameters in univariate analysis only (P = 0.0001, P = 0.003,
and P = 0.058, respectively).
CONCLUSIONS. On the basis of the results of this investigation, it is possi
ble to define a subset of patients with acute leukemia at very high risk fo
r CDC. Because of the morbidity and mortality of this infection, a targeted
prophylactic approach may be more effective and less costly than the rando
m administration of antifungal agents. (C) 2001 American Cancer Society.